Detangling Alzheimer's Disease
Author:
- Laura HelmuthLHLaura Helmuth
- 29 October 2003
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science of Aging Knowledge Environment
- Vol. 2003 (43) , 2
Abstract
Abstract: Alzheimer's disease afflicts 4.5 million people in the United States, and the number is expected to rise to 16 million by the year 2050, as the population ages. Researchers are scrambling to find genetic risk factors, decipher disease mechanisms, and develop reliable diagnostic tests that detect the illness at its earliest, potentially most treatable stage. Using these findings, they hope to devise new therapeutic approaches. Current clinical trials are assessing novel techniques that stall or reverse Alzheimer-like neuropathology in mice.Keywords
This publication has 59 references indexed in Scilit:
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsJournal of Cell Biology, 2003
- Bad for the Heart, Bad For the Mind?Science, 2001
- Tauists and βaptists United--Well Almost!Science, 2001
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotectiveNeurobiology of Aging, 2000
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Aging and Alzheimer's Disease: Lessons From the Nun StudyThe Gerontologist, 1997
- Rapid induction of Alzheimer A beta amyloid formation by zincScience, 1994
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984